Godavari Drugs Limited

GODAVARI6

INE362C01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:56 31/05/2024 pm IST			5-day change	1st Jan Change
93 ^INR	+2.14%		-0.27%	+3.26%

13/02	Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
13/02	Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director	CI

Godavari Drugs Limited Announces the Resignation of Kirti Kumar Jain from the Office of Whole-Time Director

April 20, 2022 at 01:21 pm IST

Godavari Drugs Limited announced that Board has accepted the resignation of Mr. Kirti Kumar Jain from the office of Whole-time Director of the company due to personnel reasons. His last working day will be April 19, 2022.

Latest news about Godavari Drugs Limited

Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02	CI
Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director	13/02	CI
Godavari Drugs' Profit Flat in Fiscal Q2	15/11	MT
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11	CI
Godavari Drugs Limited Announces Resignation of Ramesh Babu Telugu from the Post of Independent Director	11/23/11	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	21/23/21	CI
Godavari Drugs Limited Approves the Appointment of Mr. Venkatesh Achanta as Company Secretary	29/23/29	CI
Godavari Drugs Limited Announces Executive Changes	15/23/15	CI
Godavari Drugs Limited Announces Resignation of Mrs. Rashmi Agarwal as Company Secretary and Compliance Officer	14/23/14	CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14	CI
Godavari Drugs Limited Appoints Mahendra Uday Bhalerao as Non-Executive Independent Director	28/22/28	CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	12/22/12	CI
Godavari Drugs Limited Announces Resignation of Mr. Dilip Keshavlal Patel from Post of Non-Executive Independent Director	12/22/12	CI
Godavari Drugs Limited Approves the Appointment of Mahindra Uday Bhalerao as Additional Independent Director	12/22/12	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/22/13	CI
Godavari Drugs' CFO Resigns	20/22/20	MT
Godavari Drugs Limited Announces Resignation of Kirti Kumar Jain from the CFO	20/22/20	CI
Godavari Drugs Limited Announces the Resignation of Kirti Kumar Jain from the Office of Whole-Time Director	20/22/20	CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	19/22/19	CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	19/22/19	CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/22/14	CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	14/21/14	CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	16/21/16	CI

Chart Godavari Drugs Limited

Duration

Period

More charts

Company Profile

Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. The Company operates through manufacture and sale of API and its intermediates segment. The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for APIâs, drug intermediates and fine chemicals.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GODAVARI DRUGS LIMITED	+3.26%	8.39M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B